期刊文献+

一氧化氮及其递送系统在肿瘤治疗中的研究进展 被引量:2

Research Progress of Nitric Oxide and its Delivery Systems in Tumor Therapy
原文传递
导出
摘要 一氧化氮(nitric oxide,NO)作为一种重要的内源性信号分子,参与调节生物体内的多种生理和病理活动。近年来研究发现NO在肿瘤治疗中亦能发挥重要作用,高浓度NO不仅可以通过诱导细胞凋亡抑制肿瘤细胞增殖,还对多种肿瘤治疗具有增敏作用。本文着重介绍了几类重要的NO供体以及以纳米载体为介导的NO气体治疗在肿瘤联合治疗中的研究进展。 Nitric oxide(NO), as an important endogenous signal molecule, participates in the regulation of various physiological and pathological activities in organisms. Recently, it has been found that NO also plays an important role in tumor treatment. A series of researches suggest that NO with high concentration can not only inhibit tumor cell proliferation by inducing apoptosis, but also has a sensitizing effect on various tumor therapies. This paper summarizes several important NO donors, and then reviews the research development of NO via nano-carriers in tumor combined therapy.
作者 王柯厶 邱利焱 WANG Kesi;QIU Liyan(Department of Polymer Science and Engineering,Zhejiang University,Hangzhou 310027,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2021年第17期2140-2149,共10页 Chinese Journal of Modern Applied Pharmacy
基金 国家自然科学基金项目(81872825)。
关键词 一氧化氮 纳米载体 肿瘤治疗 供体 联合治疗 nitric oxide nano-carriers tumor therapy donor drugs combined therapy
  • 相关文献

参考文献4

二级参考文献21

  • 1任正刚,刘银坤,Ziqiu Wang,Sid Kar,Brian I Carr.多途径丝裂原激活的蛋白激酶介导一氧化氮引起的肝癌细胞凋亡[J].肿瘤,2004,24(5):459-463. 被引量:3
  • 2陈仕珠.乙型肝炎病毒疫苗和乙肝免疫[J].世界华人消化杂志,2006,14(27):2661-2667. 被引量:15
  • 3周翡,罗金红,李琦,李宁,杨丽娟,王理伟.内皮一氧化氮合酶表达与人胃癌血管生成表型及不良预后的相关性研究[J].肿瘤,2007,27(4):290-293. 被引量:3
  • 4SHIMAOKA M, IIDA T, OHARA A, et al. NOC, a nitric-oxidereleasing compound, induces dose dependent apoptosis in macrophages [ J ]. Biochem Biophys Res Commun, 1995, 209 ( 2 ) : 519-526.
  • 5ZHOU H, HUANG L, SUN Y, et al. Nitric oxide-donating aspirin inhibits the growth of pancreatic cancer cells through redox-dependent signaling [J]. Cancer Lett, 2009, 273 (2): 292-299.
  • 6SHIOTANI A, IISH H, ISHIGURO S, et al. Epithelial cell turnoverin relation to ongoing damage of the gastric mucosa in patients with early gastric cancer increase of cell proliferation in paramaligant lesions [ J ]. J Gastroenterol, 2005, 40 (4) :337-343.
  • 7BAUER J A, BOOTH B P, FUNG H L. Nitric oxide donors: biochemical pharmacology and therapeutics [ J ]. Adv Pharmacol, 1995, 34:361-381.
  • 8MATHEWS M B, BERNSTEIN R M,TRANZA B R Jr. Identity of the proliferating cell nuclear antigen and cyclin [ J ]. Nature, 1984,309(5966) :374-376.
  • 9QUEMENEUR L, GERLAND L M, FLACHER M, et al. Differential control of cell cycle, proliferation, and suivival of primary T lymphocytes by purine and pyrimidine nucleotides [J]. J Immunol, 2003, 170 (10) :4986-4995.
  • 10NICHOLSON D W. Caspase structure, proteolytic substrates, and function during apoptotic cell death [ J]. Cell Death Differ, 1999, 6 (11) : 1028-1035.

共引文献139

同被引文献39

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部